Roflumilast topical - Arcutis Biotherapeutics
At a glance
- Drug Originator Arcutis Inc
- Drug Licenced by AstraZeneca; Hangzhou Zhongmei Huadong Pharmaceutical
- Drug Class Aminopyridines; Anti-inflammatories; Antiallergics; Antiasthmatics; Antipsoriatics; Benzamides; Chlorinated hydrocarbons; Cyclopropanes; Fluorinated hydrocarbons; Skin disorder therapies; Small molecules
- Mechanism of Action Type 4 cyclic nucleotide phosphodiesterase inhibitors
- USA Patent Applicants ARCUTIS
- USA Patents 17
- NDAs 2
- International Patents 51
- Patent Applications 4,393
Disclaimer